SGMO

#3170
Sangamo Therapeutics, Inc. Common Stock
0.43
-4.44%
Sector:
Base:
Profit Currency:
Daily Range
0.43
0.43
Year Range
0.35
1.07
Daily Change
-4.44%
Monthly Change
+13.16%
6 month change
-20.37%
Year Change
-56.12%
Previous Close
0.45
Open
0.43
Bid
Ask
Low
0.43
High
0.43
Volume
17
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM

Sangamo Therapeutics Inc

Sangamo Therapeutics, Inc. is an American biotechnology company based in Brisbane, California, that develops cell and gene therapies for severe genetic diseases.

News